NanoCor Therapeutics
A biotechnology company developing intracellular genetic protein therapy to treat chronic heart failure
3
Funding Rounds
$17.6m
Money raised
Overview
A biotechnology company developing intracellular genetic protein therapy to treat chronic heart failure
-
Websites:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company NanoCor Therapeutics has raised a total of $3.75m in funding over 3 rounds.
Key Insights:
- NanoCor Therapeutics funding round, September 2007: $3.75m
- NanoCor Therapeutics Series B round, September 2007: $6.3m
- NANOCOR THERAPEUTICS INC funding round, June 2009: $7.5m
NanoCor Therapeutics funding round, September 2007
$3.75m
NanoCor Therapeutics Series B round, September 2007
$6.3m
NANOCOR THERAPEUTICS INC funding round, June 2009
$7.5m
Industries
NanoCor Therapeutics is active in the following industries: